• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

124.53 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
March 11, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried ↗
March 10, 2025
The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval. 
Via Investor's Business Daily
News headline image
1 Growth Stock to Target This Week and 2 to Ignore
March 05, 2025
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
News headline image
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
February 27, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom... 
Via StockStory
Topics Artificial Intelligence
News headline image
Breaking Down iRhythm Technologies: 6 Analysts Share Their Views ↗
February 21, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For February 20, 2025 ↗
February 20, 2025
 
Via Benzinga
News headline image
Critical Insights From iRhythm Technologies Analyst Ratings: What You Need To Know ↗
December 03, 2024
 
Via Benzinga
News headline image
Forecasting The Future: 6 Analyst Projections For iRhythm Technologies ↗
October 31, 2024
 
Via Benzinga
News headline image
iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars
February 20, 2025
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 24% year on year to $164.3 million. The company expects... 
Via StockStory
News headline image
iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
February 20, 2025
From iRhythm
Via GlobeNewswire
News headline image
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
February 19, 2025
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. 
Via StockStory
News headline image
iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
February 06, 2025
From iRhythm
Via GlobeNewswire
News headline image
Earnings Preview For iRhythm Technologies ↗
October 29, 2024
 
Via Benzinga
News headline image
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 30, 2024
From iRhythm
Via GlobeNewswire
News headline image
Top 3 Robotics and Automation Stocks for the Next AI Boom
December 13, 2024
The next wave of AI will include interactive and autonomous AI and these three companies are making inroads into these areas today 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
News headline image
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
November 20, 2024
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
November 18, 2024
Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economic... 
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
November 05, 2024
From iRhythm
Via GlobeNewswire
News headline image
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
November 01, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
October 30, 2024
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies Announces Third Quarter 2024 Financial Results
October 30, 2024
From iRhythm
Via GlobeNewswire
News headline image
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
October 28, 2024
From iRhythm
Via GlobeNewswire
News headline image
Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? ↗
October 27, 2024
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? 
Via Benzinga
Topics Government
News headline image
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
October 25, 2024
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results ↗
October 22, 2024
 
Via Benzinga
News headline image
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says ↗
October 22, 2024
FDA approves iRhythm's 510(k) submission for Zio AT device. A second approval may come soon, enhancing the company's mobile cardiac telemetry services. 
Via Benzinga
News headline image
Crude Oil Rises Sharply; 3M Posts Upbeat Earnings ↗
October 22, 2024
 
Via Benzinga
News headline image
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday ↗
October 22, 2024
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap